
Loading, please wait...

Loading, please wait...

Traditional bone grafts often struggle with the complex requirement of maintaining a functional blood supply and nervous system integration. However, recent research has introduced a transformative "bottom-up" approach to Vascularized Bone Tissue Engineering. By using modular microtissue units, scientists have successfully integrated angiogenesis and neurogenesis into a single tissue-engineered bone (TEB) construct. This innovation overcomes the limitations of traditional scaffolds that often lack the micro-architecture necessary for deep tissue survival and functional integration.
Researchers developed vascular-neural-bone microtissues using a three-dimensional (3D) coculture of bone marrow mesenchymal stem cells (BMSCs), endothelial progenitor cells (EPCs), and Schwann cells (SCs). Unlike top-down methods that seed cells onto large scaffolds, this bottom-up strategy uses these microtissues as building blocks. These units are encapsulated within gelatin methacrylate (GelMA) hydrogels to create large-scale grafts. Consequently, the resulting structure mimics the intricate vascular and neural networks found in natural bone tissue.
The study demonstrated that the GelMA/MSC/EPC/SC constructs significantly enhance angiogenesis, neurogenesis, and osteogenesis simultaneously. Molecular and cellular analysis confirmed the feasibility of this protocol across multiple levels of biological organization. This tri-lineage approach ensures that the newly formed bone is not only structurally sound but also physiologically active. Furthermore, the pre-vascularization aspect allows for faster anastomosis with the host circulatory system, which is critical for the clinical treatment of large-scale bone defects.
In the clinical setting, especially for complex fractures or tumor reconstructions in India, these findings offer a path toward more reliable bone grafts. The integration of Schwann cells promotes nerve regeneration, while EPCs drive the formation of essential capillary networks. Therefore, this multifunctional approach provides a comprehensive solution for patients suffering from critical-sized bone defects that typically resist standard healing processes.
Traditional bone grafting often relies on seeding cells onto a pre-made scaffold, which may not allow for deep cell penetration or complex vessel formation. The bottom-up approach uses tiny, pre-formed modular microtissues as building blocks to create a more naturally integrated and vascularized structure from the inside out.
Schwann cells are essential for neurogenesis. Including them ensures that the tissue-engineered bone develops a neural network alongside blood vessels. This crosstalk between nerves and bone is vital for proper bone metabolism and long-term functional recovery.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.
References
1. Cao G et al. Developing tissue-engineered bone with pre-vascularization and innervation using a bottom-up approach involving MSC/EPC/SC microtissues. Biofabrication. 2026 Feb 27. doi: 10.1088/1758-5090/ae4b6a. PMID: 41759217.
2. Annamalai RT et al. Multimodular vascularized bone construct comprised of vasculogenic and osteogenic microtissues. Biomaterials. 2019;189:63-73.
3. Nichol JW, Khademhosseini A. Modular tissue engineering: engineering biological tissues from the bottom up. Soft Matter. 2009;5(7):1312-1319.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers developed a bottom-up modular approach for bone regeneration using MSC/EPC/SC microtissues to integrate blood vessels and nerve fibers....
5 months ago

A study evaluates the diagnostic performance of repeat transthoracic echocardiography in suspected infective endocarditis, showing modest improvements in lesion detection but limited incremental value within a multimodality imaging approach.
Today

A multicenter study identifies a three-metabolite gut microbiota panel (3-hydroxydecanoic acid, γ-Glu-Leu, and propionic acid) for early risk stratification of gestational diabetes mellitus in the first trimester, offering superior predictive accuracy over standard clinical risk factors before 24 weeks.
Today

A breakthrough study reveals how METTL14-mediated m6A methylation of KRT17 drives pulmonary arterial smooth muscle cell proliferation via LCN2, offering new therapeutic targets for pulmonary vascular remodeling.
Today

A novel multi-strategy C2 screw placement protocol integrating fusion cage support and vertebral artery mobilization achieves superior fusion rates and zero vascular complications in complex upper cervical spine surgery, offering a reliable solution for high-riding vertebral artery cases.
Today

Discover clinical pitfalls in diagnosing SGLT2 inhibitor ketoacidosis in the ICU. Learn how cardiac surgery and GLP-1 agonist interactions trigger euglycemic DKA and explore management strategies.
Today